🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sensitivity and Tests for Evaluation of Plantar Fasciopathy

RecruitingNAAges 18 Years - 18 YearsAllIstituto Ortopedico Rizzoli
NCT07567807 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Plantar fasciopathy (PF), one of the leading causes of foot pain, affects up to one in ten individuals in their lifetime. Characterized by pain and structural alterations at the proximal insertion of the plantar fascia on the calcaneus, the term "PF" has replaced "plantar fasciitis," as degenerative tissue changes predominate over inflammatory processes. The pathogenesis of PF remains incompletely understood but appears to involve the gastrocnemius muscle, which is part of an integrated biomechanical unit including the calcaneus and the plantar fascia. Diagnosis is primarily based on clinical history and physical examination, while imaging modalities such as ultrasound and magnetic resonance imaging assist in excluding differential diagnoses. A simple clinical test to distinguish PF from other causes of heel pain, such as plantar fat pad syndrome or Baxter's nerve entrapment, could impr

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * PF group: * Patients on the waiting list at Clinic I of the Rizzoli Orthopaedic Institute for surgical intervention with a diagnosis of recalcitrant PF lasting at least 12 months * Age \>18 years * MRI of the foot and ankle negative for other local causes of pain included in the differential diagnosis of PF * Negative electromyography for tarsal tunnel syndrome * Control group: * Age \>18 years * Outpatients followed at Clinic I for conditions unrelated to the foot and ankle, with no clinical history of foot pain or pathology in the preceding 12 months Exclusion Criteria: * PF and control groups: * Minor patients * Patients with diagnosed rheumatologic diseases currently under pharmacological treatment * Patients with diabetes or diabetic neuropathy * Pregnant women
💊

What it tests

  • Gastroc Sign
  • Tenderness at the Medial Calcaneal Tuberosity
  • Silfverskiöld Test
📍

Where

1 site
IRCCS Istituto ortopedico Rizzoli
Bologna, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy